FURTHER EXPERIENCES WITH THE USE OF SODIUM DIPHENYL HYDANTOINATE IN THE TREATMENT OF CONVULSIVE DISORDERS
Abstract
In 227 of 267 patients previously refractory to other forms of therapy, sodium diphenyl hydantoinate has been found to be an effective, non-sedative and relatively non-toxic means of controlling or reducing convulsive seizures over periods varying from two months to two years. A more prolonged study on a larger series of cases is necessary to establish its place in the treatment of patients with convulsive seizures.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
